Cite

HARVARD Citation

    Desai, S. et al. (2021). Ibritumomab Tiuxetan Radioimmunotherapy for Primary Gastrointestinal Follicular Lymphoma. Oncologist. pp. e2079-e2081. [Online]. 
  
Back to record